Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Renovion

Renovion
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$492K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of an advanced therapy designed to treat chronic inflammatory airway diseases. The company's therapy develops a drug for patients who have received a bilateral lung transplant, offering treatment for cystic fibrosis, asthma and chronic obstructive pulmonary disease (COPD), enabling patients to avail safe common organ transplant procedures and lead a healthy life.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 900 Martin Luther King, Junior Boulevard
  • Suite A
  • Chapel Hill, NC 27514
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Renovion’s full profile, request a free trial.

Renovion Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 05-Feb-2019 $492K 00.000 Completed Pre-Clinical Trials
3. Angel (individual) 15-May-2018 00000 00.000 Completed Pre-Clinical Trials
2. Seed Round 17-Jan-2017 $1.87M $1.87M 00.000 Completed Pre-Clinical Trials
1. Accelerator/Incubator 22-Sep-2016 $50K Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Renovion Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spyryx Biosciences Venture Capital-Backed Durham, NC 00 000.00 00000000000 000.00
0000 000000000000 Venture Capital-Backed Austin, TX 0 000.00 00000000000 000.00
000000000 Venture Capital-Backed Atlanta, GA 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Montreal, Canada 00.000 0000000000 0 00.000
000000 00000000000 Formerly VC-backed Norwood, MA 00 00.00 0000000000 00.00
To view this company’s complete list of competitors, request access »

Renovion Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Council of Entrepreneurial Tech Transfer Other 000 0000 000000 0

Renovion Executive Team (2)

Name Title Board
Seat
Contact
Info
Daniel Copeland Chief Executive Officer & Board Member
Carolyn Durham Ph.D Chief Scientific Officer

Renovion Board Members (7)

Name Representing Role Since Contact
Info
Daniel Copeland Renovion Chief Executive Officer & Board Member 000 0000
Derek Winstanly Self Chairman 000 0000
Fred McCoy Self Board Member 000 0000
James Donahue MD Self Scientific Advisory Board Member 000 0000
Robert Ryan Ph.D Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »